chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 23 year old female patient with no pertinent medical history or allergies who on 27-JAN-2009 was vaccinated IM with the first 0.5 ml dose of GARDASIL. On 26-MAR-2009 the patient was vaccinated IM with the second of GARDASIL (lot # 0074Y). On 02-JUN-2009 the patient was vaccinated IM with the third 0.5 ml dose of GARDASIL (lot # 0294Y). There was no concomitant medication. After the patient received the second dose she experienced persistent headaches. At the time of this report, the patient had not recovered. The patient sought medical attention through a phone call. Headaches were considered to be disabling. Additional information has been requested.
Dry eyes.  About two weeks after  my second Pfizer shot (3/2021), I had a sudden onset dry eye condition (right eye very dry upon waking). This has persisted since that time, though early in Nov 2021, I would have occasional days when I would wake and it would be normal. Then I got my booster on 11/11/21.  Now, about 2 weeks later, I am waking with both eyes dry, and done dryness during daytime. It?s not clear to me if the vaccine caused dry eye as a side effect or if it tipped off some auto immune process, but after the increased effect post-booster, with essentially the same timing as the onset relative to shot #2, I have virtually no doubt this is causally related to the vaccine.
Headache, Sedation, Arthralgia, Fever, NauseaVomiting, chills and fatigue. pain, redness, itching and swelling at the injection site. Narrative:  Other Relevant History:
Intermittent dizziness since received vaccine and blurry vision. Heart racing daily since received shot.  Soreness in right arm where received shot. Internal pain in mid to back of upper left arm (arm not with injection)
Nose bleed, left nostril.  First occurred 11/1/21 at 3AM.  Reoccurred 11/11, 11/13, 11/15, 11/17, 11/18 & 11/20.  Five of these times I used Oxymetazoline HCI spray to stop it. Went to Dr. on 11/22/21 who cauterized the blood vessel to stop the bleeds from recurring.
20 minutes after receiving Janssen vaccine patient started complaining of nausea, facial swelling and tightness in throat. Patient was given 50 mg P.O. Benedryl. Throat tightness persisted and patient started with a dry, hacking cough. Patient was given 0.5 mg IM epinephrine and paramedics were called. Patient was alert, oriented, and able to speak at this point in time. She was evaluated and transported to  ER.  Reports indicate that she received fluids, was observed, and eventally discharged later that evening.
Skin sores in throat and mouth, too much sleeping, night sweats, swelling joints, feet, and ankles, urinary frequency weakness, pain legs, knee right, lower back, ankles, hips, joints, muscle pain and rib cage, respiratory tract infection (pneumonia), respiratory problems upper airway obstruction, rhinitis, infections chronic to include ear and sinus, leukocytosis, sometime dizziness, irritable, nausea, vomiting, hair loss (alopecia), fatigue, arthritis, tachycardia, high cholesterol, vertigo, hemorrhoids, gastritis, chills, fever (over 40), cramps leg, cough, constipation, chest pain. Initial report received with attached records documenting a diagnosis of sepsis 2' to upper respiratory infection on 07/08/2004 as well as labs revealing hyperlipidemia and elevated LFTs frpm 8/26/2006.  MR received from March 2004 to Oct. 2006 for visits for the following problems: dyslipidemia (03/2005 and 07/2006) as well as low back pain, and knee arthralgias (10/31/2006) On OV of 3/29/2005 pt. reports no complaints. PE negative. C/o of joint pain (low back, hands, and knees) on 07/2006 10/2006. PEs negative except for +joint pain  treated with Sulindac.
swelling in arm at the injection area; under my arm it is sore it feels heavy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), for COVID-19 Immunization; Bnt162b2 (Dose 2, Single), for COVID-19 Immunization. The following information was reported: VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "swelling in arm at the injection area"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "under my arm it is sore it feels heavy".  Additional Information: Patient received booster shot on the 07. There was swelling in arm at the injection area, but the thing was under arm it was sore it feels heavy. Reporter seriousness for all events was unspecified.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse practitioner concerning a female who was vaccinated with GARDASIL vaccine first dose. Concomitant therapy included DEPO-PROVERA. On approximately 15, Feb 2007, the patient experienced continuing dizziness when administered GARDASIL vaccine. A blood test was performed and the patient was found to be anemic. The nurse practitioner was unsure whether to continue further series with GARDASIL vaccine. Unspecified medical attention was sought. As of 01, Mar 2007, the patient's continuing dizziness and anemic persisted. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/6/2007. In follow up, the nurse practitioner did not recall the patient and had no further information to provide.
Patient received COVID19 Pfizer BioNTech vaccination approximately 1:10p. After vaccination administering RPH requested patient wait for 15 minutes prior to leaving.  Approximately 1:20p patient began to feel faint - lightheadness, clammy skin, and pale skin. RPH took pulse over 30 second time period and reported HR of 44. Patient was offered water and RPH assisted patient to lay on the floor with legs raised above head. Skin color slowly returned.  Pulse was taken again and came back up to the low 90s. Patient laid on floor for 15 minutes prior to being assisted by RPH to sit in chair. Patient then sat in chair for approximately 10 minutes prior to feeling comfortable leaving. EMS was not called to scene. Patient stated that he had not eaten prior to vaccination. RPH counseled patient to eat prior to receiving second vaccine and to inform vaccinator prior to second dose of previous reaction.
Headaches, neck pain, diarrhea 5-6 x /day, slight fever intermittently, chills. Taking ibuprofen.
This spontaneous report was received from a registered nurse and refers to a 16-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 19-DEC-2018, the patient was vaccinated with improperly stored dose of VAQTA, lot # R018935, expiration date 05-SEP-2019 (dose and route of administration were not reported). Administered dose of vaccine experienced the temperature excursion of 31.1 Fahrenheit degrees (F) (below 32 F/ 0 Celsius degrees) (30 cycles) for 35 hours 30 minutes. There were no previous excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported. This is one of multiple reports received from the same reporter (It was reported that it was unknown which lot numbers of each specific vaccine were administered to which patient). Sender's Comments: US-009507513-1901USA000071.
Throwing up blood; This is a spontaneous report from a contactable consumer. A 40-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 12Aug2021 (Lot Number: FD8448) as single dose (at age of 40-year-old) for covid-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 12Aug2021 patient experienced throwing up blood. Reporter stated that patient got first dose of Pfizer Vaccine on 12Aug2021 after 12:10 at (Withheld) and he was throwing up blood at the time of the report. Reporter stated that patient was not treated for the event. Second dose vaccination date was reported as 02Sep2021. Outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of herpes simplex in a 66-year-old female patient who received SHINGRIX (batch number HG4P3, expiry date unknown) for prophylaxis. On 20th April 2018, the patient received SHINGRIX (intramuscular) .5 ml. On an unknown date, immediately after receiving SHINGRIX, the patient experienced herpes simplex. The patient was treated with Valacyclovir. On an unknown date, the outcome of the herpes simplex was unknown. It was unknown if the reporter considered the herpes simplex to be related to SHINGRIX. Additional information was reported as follows: The patient received a dose of SHINGRIX and shortly after broke out with a herpes simplex lesion. The reporter did not directly speak to the patient. This information was heard through another pharmacist. She was unsure when the lesions appeared after the first injection. On 22nd July 2018, the patient was vaccinated with the 2nd dose of SHINGRIX (batch number: Z9RR4, expiry date: unknown), dose as 0.5 ml by intramuscular route. The reporter vaccinated the patient with the 2nd dose and had not been contacted about reoccurrence of the event again after the 2nd dose.
Back ache, armpit ache, pimple looking bumps on arms chest and back.
developed a "severe reaction"; body aches; constant rash; burning sensation on the back; fever; she feels uncomfortable; has stomach issues; Tired; This is a spontaneous report from a contactable consumer or other non hcp. A 60-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number was not reported expiry date was not reported) dose 1 via an unspecified route of administration on 04Mar2021, as FIRST DOSE, SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient developed a severe reaction, with body aches, constant rash, burning sensation on the back, fever, she feels uncomfortable, tired, and has stomach issues. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Provider order PENTACEL and pt was give PEDIARIX, asked the provider to check vaccine with me and she did and said it was the correct one.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug allergies and concomitant medications were not reported. The pharmacist reported that on 23-OCT-2017 the patient was inadvertently vaccinated with expired dose of ZOSTAVAX 19400 PFU (lot # M033910, Expiry date: 17-OCT-2017) for prophylaxis. Concomitant therapies included sterile diluent (Lot # M004656, Expiry date: 13-AUG-2018). No adverse event reported. There was no product quality complaint involved. Sender's Comments: US-009507513-1710USA014683.
Mother states that evening after vaccines were administered pt was very irritable and crying for 30-40 min periods of time. Pt was inconsolable. Took pt to ER because crying got  worse. No c/o fever, V, D or convulsions. Pt was diagnosed at ER with constipation. On visit to our facility on 04/04/05 no OM present, no constipation.
HPI: Patient is a * year old * who presents following administration of the first dose of Pfizer COVID19 vaccine in the left deltoid.  She states that immediately following administration of the vaccine, she started to feel lightheaded with ?fuzzy vision,? and pain with swallowing.  She denies a history of anaphylaxis.  She affirms seasonal allergies and confirms that she was feeling ?stuffy? this morning.  She affirms that she ate and drank this morning without odynophagia.  She relates that there was a big family argument that is causing her to feel stressed at this time as well.   She affirms pleuritic chest pain, odynophagia, epigastric abdominal pain, headache, lightheadedness, and blurry vision.  She denies chest pain, difficulty breathing, swelling of the face/lips/tongue/throat, skin rash/itching, cramping abdominal pain, nausea, and vomiting.     Exam: GEN: Alert and oriented x 4, NAD.  Patient appears to have a developmental delay secondary to eye contact avoidance, slow to respond, and speech impediment. HEAD: NCAT EYES: PERRL, EOMI ENT: Ears normal, Nose normal, OP normal, no evidence of angioedema NECK: Supple, without LAD.  CV: RRR, no m/r/g PULM: Shallow, guarded breathing at rest, but clear to auscultation bilaterally with deep inspiration, no accessory muscle use ABD: Soft, no tenderness. SKIN: No rashes, skin warm and dry.  No erythema or edema of the injection site. MSK: FROM, MS 5/5 NEURO: Alert and oriented x 4, CN 2-12 grossly intact, no ataxia, gait steady   Clinical Impression/Field Tx: Vital signs stable and physical exam within normal limits, however, patient continued to report odynophagia, pleuritic chest pain, abdominal pain, lightheadedness, and blurry vision, even after giving patient snack/drink and reclining her with lower extremities above the level of heart and head.  EMS called to the scene for further evaluation.   Instructed patient and parent to consult their PCP regarding the post-vaccination reaction.  Patient and parent instructed to go to emergency department should she develop chest pain, difficulty breathing, swelling of the face/lips/mouth/tongue/throat, or cramping abdominal pain with nausea/vomiting.  Patient and parent demonstrated understanding of post-vaccination instructions.     Medications administered: None   Disposition:  EMS contacted due to patient not improving. Care transferred to EMS .  No workup was performed by EMS and they instructed the parent of the patient to take the patient to ER via private car for further evaluation.  Father was amenable to plan and signed form.
patient described as inconsolable, very upset for 12 hours after immunizations.  Less fussy then for remainder 24 hours.
Reporter started having weakness in the arms and legs. Reporter said that he lost strength in both sides and is having more weakness on the left side.
This spontaneous report as received from a pharmacist via company representative referring to a patient of unknown age. Concurrent condition and medical history were not reported. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency, route and lot# not reported). Concomitant therapy was not reported. On an unknown date the patient experienced shingles. It was unspecified if the patient sought medical attention. The outcome of shingles was unknown. Causality was not reported. Additional information has been requested.
Symptoms are - sore armpits, lightheaded, tingly lips / fingers / tongue but the tingly sensation only happens when I get dizzy from being lightheaded. All happened yesterday and today (within 2 days) of the vaccine
patient received both flu and covid booster in left arm during at a clinic. She reports pain from armpit to elbow,muscle pain and cannot lift arm. Suggested patient check with physician.
After the vaccine couple hours exp headache and was very tired couldn't get out of bed. I contacted chiropractic that day was seen that evening. He was placed on a treatment plan for sciatic nerve.
Patient with 2 Pfizer vaccinations, last dose 06/30/21, who admitted with positive COVID test.  Provider d/c note below:  "Brief Summary of Hospital Stay: Per H&P: Patient is a 88 YO female with past medical history of rheumatoid arthritis, osteoarthritis, depression, GERD, HTN, and osteoporosis presenting to Hospital with complaint of worsening generalized weakness for the past 3 days. The patient lives at home alone and is home bound. She has care givers that come to her house.    Work up revealed patient was covid positive and had a UTI. Patient was largely asymptomatic for Covid apart from worsened confusion which was also attributed to UTI. She was treated with Rocephin and Keflex until completion of course. Patient did suffer from hospital acquired delirium and some agitation which improved with Seroquel. Assessment by therapy deemed patient appropriate for SNF, however it was important for family that she return home. Hospitalization was prolonged due to care coordination delays at home in finding caregivers through insurance. Patient was ultimately discharged with wheelchair after caregivers were established.  She was started on Seroquel nightly, which was the only medication change made to her regimen.   Issues Requiring Follow Up: PCP"
10/01/2021-began with calf pain, like I was having a clot, when stepping on the right leg. My right leg was very red on Tuesday the 5th. On 10/04/2021 I went to the hospital and I was admitted. I am receiving antibiotics by IV to treat cellulitis in my right leg.
Information has been received from a nurse, via a company representative, concerning a 20 year old female patient, who on approximately 17-JUN-2007 ("two months ago") was vaccinated with the first dose, 0.5ml, of Gardasil.  On 17-JUN-2007, the patient fainted following the vaccination. On 17-AUG-2007, the patient was vaccinated with the second dose, 0.5ml, of Gardasil, and again fainted following the vaccination.  The nurse stated "it was difficult to bring her out of it," but confirmed that after being awakened, the patient fully recovered and walked out of the office.  She added that the episodes lasted "a few minutes."  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 9/17/2007. Initial and follow-up information has been received from a registered nurse and a licensed practical nurse (LPN), concerning a 20 year old female student with no known allergies and no previous history of fainting with other injections, who on 14-JUN-2007 was vaccinated with the first dose, 0.5ml, of GARDASIL (lot #657622/0388U). There was no illness at the time of vacination. Following the vaccination she fainted, and was observed by the staff for "at least 30 minutes," with vital signs reported as stable. On 06-AUG-2007 (previously reported as 17-AUG-2007), the patient was vaccinated with the second dose, 0.5ml, of GARDASIL (lot #657868/0523U), and again fainted following the vaccination. The RN indicated that the patient "came out of it almost immediately." However, the LPN who administered the vaccine stated that the episodes lasted "a few minutes," and added that it was difficult to bring her out of it." The RN stated that the patient was again observed for at least 30 minutes with stable vital signs. The patient fully recovered and walked out of the office. The patient sought unspecified medical attention. Additional information is not expected.
Reported by clinic nurse child had red, swollen L leg. Started on antibiotic therapy 3/28/03-no diagnosis.
For approximately 12 hours on February 2,2021 ( the day following my second Pfizer injection) I had chills and a fever of about 100.3  degrees.
Broke out with red, itchy rash. This has continued on and off with 3 more outbreaks since.
I26.9; ACUTE PULMONARY EMBOLISM 2/22/2023 ACUTE PULMONARY EMBOLISM; J96.00; ACUTE RESPIRATORY FAILURE 2/22/2023 ACUTE PULMONARY EMBOLISM.
Atrial Fibrillation.  Lasted about a couple hours, needed to take medication.   Had not had an episode in several months and was feeding good.
Menstrual bleeding in the middle of birth control pack, lower left abdominal pain and menstrual cramping. Cramping about a day before bleeding started.
thawed upon arrival on 09Apr2021, vials were stored in the refrigerator upon shipment arrival; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (thawed upon arrival on 09Apr2021, vials were stored in the refrigerator upon shipment arrival) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (thawed upon arrival on 09Apr2021, vials were stored in the refrigerator upon shipment arrival). At the time of the report, PRODUCT STORAGE ERROR (thawed upon arrival on 09Apr2021, vials were stored in the refrigerator upon shipment arrival) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-163779 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-163779:Same reporter
Boy born healthy. Pediatrician kept saying "beautiful, big, fat healthy baby boy". Ate everything, playful, attended Nursery, swimming and other activities. Out of dozens of candidate to enrollment at a school, he was admitted having passed examinations and meeting with teachers and psychologists. Received various vaccinations. First flu, he reacted bad, We never knew. Government kept advertising Flu Campaign. He received the second Flu shot. He was like having received a "short circuit". After 4 days, he was a different person. Lost eye-contact, ability to speak, stomach was ruined, he was lost, even body odor, breath, skin color, hair changed. After a nightmare of inquiries everywhere, he was found with High Level of Mercury poisoning. He started with Chelation and we are financially ruined but hope he will make it and defeat mercury poisoning a.k.a. Autism.  11/15/2007 MR received from PCP including multiple consultations.  Initial visit for 3 yr old check on 10/3/2004.  Noted were: delayed speech, not yet toilet trained. 4 yr WCC noting that speech is improving slowly and now toilet trained. Other evals report child reaching developmental milestones until age 2, when he lost some speech and no longer maintained eye contact.  Speech-Language eval for limited receptive-expressive language.  DXd with PDD in 11/2004. Neuro consult 9/2005 in agreement with above noting greater expressive language disorder than receptive.
I was having a sore throat followed by nasal congestion. Then I was treated with Paxlovid, and I also had a fever of  100.8. I got a cough again 7 days later and the cough was nonconductive for 4 to 5 weeks. I took a home COVID test it was positive 14FEB23. The symptoms got worse.
High temperature (104-105), muscle and joint cramping. This occurred the night of the 30th. Temperature started to decrease over the next two days so did the cramping. Then starting on 4/5 I started to experience pain in the back of my head along with the sensation of heat/burning. This was accompanied by a stiff neck. This pain and stiffness persists to today. Medication prescribed by my doctor lessens the discomfort but has not rid me of the issue.